Oil Markets Nearing Critical Low Inventory Levels in Asia Europe Following Warns Carlyles Jeff Currie Micron Signals AI Boom Sustainability Accelerates Singapore Investment Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Bitcoin Dips as Optimism Over USIran Peace Talks Clashes With Rising Crypto ETF Outflows Nvidia Earnings in Spotlight Jensen Huangs Remarks on China and Trade Policy Could Move Markets Dhoot Transmission Files Updated DRHP for 1400 Crore IPO with Sebi CBSH Q1 2026 Earnings EPS Surpasses Estimates by 71 Amid Solid Operating Performance Cirrus Logic Q1 2026 Earnings EPS Beats Estimates by 86 Shares Edge Lower MMI Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Market Conditions TRINZ Q1 2026 Earnings Modest EPS Beat Amid Stable Revenue Outlook AL Q4 2025 Earnings EPS Surges Past Estimates Amid Strong Aircraft Demand GPC Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Edges Higher 1RT Acquisition Corp ONCH Holds Steady Near Resistance RangeBound Action Continues Manulife Financial MFC Edges Lower Amid Consolidation Near Key Levels W P Carey Inc WPC Mild Gain as REIT Tests Key Support Levels Myomo Inc MYO Faces Mild Pullback as Stock Nears Key Support Level Cadrenal Therapeutics CVKD Slides 52 as Support Level Comes into Focus CapitaLand Unveils 14 Billion Life Sciences Hub Geneo to Transform Science Park ODYS Q1 2026 Earnings WiderThanExpected Loss Pressures Shares Braiin Limited BRAI Surges Over 50 in a Single Session A Closer Look at the Momentum ARM Q1 2026 Earnings EPS Beats Estimates Amid Strong Licensing Demand GEMI Q1 2026 Earnings Narrowed Loss Beats Estimates as Space Station Operations Continue SLGN Q1 2026 Earnings EPS Beats Estimates by 246 Driven by Operational Efficiency GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development iSpecimen ISPC Q3 2024 Earnings Disappointing Bottom Line Sends Shares Lower CLPT Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed IBRX Q1 2026 Earnings EPS Miss as Biotech Continues PreRevenue Advancement